Formulation Development
Associated Biotech Group possess a valid WHO-GMP certification of the plant for manufacturing of Tablets, Capsules and Oral Suspension for Beta lactum, Non-Beta lactum and Cephalosporin Group.
Pursuing Innovation
The pursuit of innovative ways in offering the medicine is the basic factor in Associated Biotech Group’s culture. It not only shapes our strategy but defines our purpose and governs every facet of our operations. Our scientists have produced innovative breakthroughs in a wide range of areas, including providing the very stable β-lactum to offering Cephalosporin with the taste masking (in a very palatable form).
Formulation and Development has always been a considerable component for growth of Associated Biotech Group. Spectrums of research are carried out by our organization, ranging from development of new applications for existing products to upgrading formulation efficiency and improving drug delivery systems for antibiotic manufacturing.
Independent Formulation and Development departments staffed by well-qualified chemists are taking vivid part in research efforts. A centralized quality control and analytical research laboratory has been set to meet the domestic and international quality standards. The company has expanded operations on already existing set-up by investing in new premises, to include modern, state-of-the-art amenities, machines and equipment.
Our Formulation and Development approach ensures noteworthy vicinity of unmet medical need by leveraging our legacy in discovering and developing high-potency small molecules, semi synthetic antibiotic, as well as our growing experience and expertise in highly targeted biologics.